Altogether, these data support a new role of PrPC in the control of the cell energetic metabolism and the cell redox status, whose deregulation by pathogenic prions contributes to neurodegeneration, and introduce PDK4 as a potential therapeutic target to fight against prion diseases. This evidence concerns the gene PDK4 and prion disease.